Literature DB >> 34511825

Recurrent Pyroglutamic Acidosis in the Context of Undiagnosed Liver Cirrhosis-A Case Report.

Bradley J W Allen1, Ahmed A Abu Shanab2, Mark R Anderson2, Edward N Fogden2.   

Abstract

Metabolic associated fatty liver disease, previously known as nonalcoholic fatty liver disease, is the most common cause of chronic liver disease across all ethnic groups; however, it remains enormously underestimated.1 , 2 Sepsis, hepatotoxic medications and malnutrition in the acute settings on top of unknown cirrhosis can lead to decompensation and various metabolic complications. Pyroglutamic acidosis is a rarely recognised cause for unexplained high anion gap metabolic acidosis that is felt to be frequently underdiagnosed. Particular patients at risk include women, the elderly, those on regular paracetamol and those suffering with malnourishment or sepsis. Other risk factors include alcohol abuse and chronic liver disease (3). We present the case of a patient with recurrent episodes of pyroglutamic acidosis and encephalopathy in the context of undiagnosed nonalcoholic fatty liver disease with cirrhosis.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V.

Entities:  

Keywords:  5-Oxoprolinaemia; HIV, Human Immunodeficiency Virus; NAC, N-acetylcysteine; NAFLD, Nonalcoholic Fatty Liver Disease; NASH; NASH, Nonalcoholic Steatohepatitis; VBG, Venous Blood Gas; metabolic associated fatty liver disease; nonalcoholic fatty liver disease; pyroglutamic acidosis

Year:  2020        PMID: 34511825      PMCID: PMC8414321          DOI: 10.1016/j.jceh.2020.10.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  18 in total

Review 1.  Prediction of liver cirrhosis, using diagnostic imaging tools.

Authors:  Suk Keu Yeom; Chang Hee Lee; Sang Hoon Cha; Cheol Min Park
Journal:  World J Hepatol       Date:  2015-08-18

2.  Pyroglutamic acidosis in association with therapeutic paracetamol use.

Authors:  Robert W Hunter; Cate Lawson; Evangelia Galitsiou; Fiona Gifford; John J Neary
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

3.  Recurrent Pyroglutamic Acidosis Related to Therapeutic Acetaminophen.

Authors:  Hazem M Alhourani; Aneel Kumar; Lekha K George; Tahira Sarwar; Barry M Wall
Journal:  Am J Med Sci       Date:  2017-08-03       Impact factor: 2.378

Review 4.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

5.  Long-term patterns of urinary pyroglutamic acid in healthy humans.

Authors:  Richard S Lord
Journal:  Physiol Rep       Date:  2016-02

6.  Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study.

Authors:  Yasushi Honda; Takaomi Kessoku; Yoshio Sumida; Takashi Kobayashi; Takayuki Kato; Yuji Ogawa; Wataru Tomeno; Kento Imajo; Koji Fujita; Masato Yoneda; Koshi Kataoka; Masataka Taguri; Takeharu Yamanaka; Yuya Seko; Saiyu Tanaka; Satoru Saito; Masafumi Ono; Satoshi Oeda; Yuichiro Eguchi; Wataru Aoi; Kenji Sato; Yoshito Itoh; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2017-08-08       Impact factor: 3.067

7.  Metabolic Acidosis Due To Pyroglutamic Acid.

Authors:  Maria João Serpa; Luís Falcão; Susana Franco; Diana Repolho; Nuno Ribeiro Ferreira
Journal:  Eur J Case Rep Intern Med       Date:  2018-10-24

8.  From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.

Authors:  Kenneth I Zheng; Jian-Gao Fan; Jun-Ping Shi; Vincent Wai-Sun Wong; Mohammed Eslam; Jacob George; Ming-Hua Zheng
Journal:  Chin Med J (Engl)       Date:  2020-10-05       Impact factor: 2.628

9.  Metabolic acidosis and 5-oxoprolinuria induced by flucloxacillin and acetaminophen: a case report.

Authors:  Charlotte Lanoy; Yves Bouckaert
Journal:  J Med Case Rep       Date:  2016-06-23

10.  Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study.

Authors:  Shir Raibman Spector; Haim Mayan; Ronen Loebstein; Noa Markovits; Eldar Priel; Eias Massalha; Yuval Shafir; Itai Gueta
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.